You are leaving Medscape Education
Cancel Continue
View All
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
Latest In Oncology
All U.S. Non-U.S.

Select all that apply





          Myelodysplastic Syndrome 1557 global 1 0.50 9 0.50 0.5 Clinical Review 0 1
          Do you know how to use novel and emerging agents to treat lower-risk myelodysplastic syndrome (LR-MDS)? Start activity
          Updates in LR-MDS: What’s New and What’s on the Horizon
          View Details
          Cushing Syndrome 5000645 global 1 1.25 2 1.25 1.25 Commentary 0 1
          Join us as clinical experts and real-life patients discuss initiating appropriate investigation and referral in Cushing disease, acromegaly, Idiopathic Multicentric Castleman disease, and acute intermittent porphyria. Start activity
          Rare Disease Stories: Different But the Same
          View Details
          Myelodysplastic Syndrome 1557 global 1 0.50 0.5 Commentary 0 1
          Need help making sense of the rapidly changing diagnosis and treatment standards in higher-risk myelodysplastic syndrome (HR-MDS)? Start activity
          Practical Pearls: Staying Up to Date on Higher-Risk Myelodysplastic Syndrome
          View Details
          Bladder Cancer 821 global 1 0.50 9 0.50 0.5 Roundtable 0 1
          Listen to the latest updates on advanced bladder cancer from the annual genitourinary (GU) cancers meeting. Start activity
          Medscape Onsite: Bladder Cancer Updates From the Annual GU Meeting
          View Details
          Cardiovascular Risk Management 3029460 global 1 0.5 9 0.5 2 0.5 3 0.5 8 0.5 0.5 Clinical Brief 0 2
          Healthy diet, exercise and supplements: what are the newfound benefits? Start activity
          Medscape Now! Hot Topics in Family Medicine February 2024 Part 1
          View Details
          0 global 1 0.50 9 0.50 2 0.50 3 0.50 0.5 Roundtable 0 1
          Do you know what the most common resistance mutation to covalent Bruton tyrosine kinase inhibitors is? Start activity
          Chronic Lymphocytic Leukemia Under the Microscope: Partnering With Pathologists
          View Details
          Curated Collections
          Curated activities and resources from our partners and committee
          You Might Like
          Because you completed the activity:
          Upcoming Events